SCHEMBL13848534

SCHEMBL13848534

CCCCc1ccc(O)c2sc(N)c(C(=O)OCC)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 10/20 0.48
▸ GAA P10253 4/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ ALOX15 P16050 3/20 0.48
▸ TSHR P16473 2/20 0.48
▸ ALDH1A1 P00352 7/20 0.48
▸ HPGD P15428 5/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ FHIT P49789 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ NPSR1 Q6W5P4 2/20 0.44
▸ MAPK1 P28482 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ GRM6 O15303 5/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13869967 0.88 CA12 (0.43) MAPTGAAMEN1KMT2AALOX15
SCHEMBL13869871 0.87 MAPT (0.47) MAPTGAAMEN1KMT2AALOX15
SCHEMBL13886690 0.82 MAPT (0.59) MAPTGAAMEN1KMT2ATSHR
SCHEMBL13848532 0.81 MAPT (0.49) MAPTGAAMEN1KMT2AALOX15
SCHEMBL3984848 0.81 MAPT (0.67) MAPTGAAMEN1KMT2AALOX15
SCHEMBL3990334 0.74 MAPT (0.51) MAPTGAAMEN1KMT2AALOX15
SCHEMBL24671856 0.72 ALDH1A1 (0.68) MAPTGAAMEN1KMT2AALOX15
SCHEMBL2925906 0.72 TSHR (0.67) MAPTGAAMEN1KMT2AALOX15
SCHEMBL13848533 0.70 MAPT (0.49) MAPTGAAMEN1KMT2AALOX15
SCHEMBL13869904 0.69 SMN1; SMN2 (0.51) MAPTGAAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828197-B1 NOVEL SUBSTITUTED THIOPHENEPYRIMIDINONE DERIVATIVES AS INHIBITORS OF 17ß-HYDROXYSTEROID DEHYDROGENASE SOLVAY PHARM GMBH (DE) 2009-05-13 — — EP disclosed
US-7524853-B2 Compounds and their use in therapy SOLVAY PHARMACEUTICALS B.V. (NL) 2009-04-28 — — US disclosed
US-7524853-B2 Compounds and their use in therapy SOLVAY PHARMACEUTICALS B.V. (NL) 2009-04-28 — — US disclosed
US-7465739-B2 Compounds and their use in therapy SOLVAY PHARMACEUTICALS B.V. (NL) 2008-12-16 — — US disclosed
US-7465739-B2 Compounds and their use in therapy SOLVAY PHARMACEUTICALS B.V. (NL) 2008-12-16 — — US disclosed
Send feedback